Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04335331 · ClinicalTrials.gov registry record

PreDM Clinical Decision Support Intervention

A clinical trial, sponsored by Northwestern University.

Completed
Registry status
7,424
Enrollment target

NCT04335331: Completed study, sponsored by Northwestern University.

NCT04335331 is a clinical trial that has completed, run by Northwestern University. The registered enrollment target is 7,424 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04335331 has completed, sponsored by Northwestern University.

COMPLETED
Registry status
7,424 participants
Enrollment target

Study Summary

Clinical practice guidelines recommend intensive lifestyle interventions and metformin to prevent or delay type 2 diabetes; yet these treatments are not routinely used among the 86 million U.S. adults with prediabetes who may benefit from them. While clinical decision support (CDS) represents an effective approach for delivering guideline-based care, the potential of this strategy to improve diabetes prevention efforts has not been definitively tested. This study developed the novel Prevent Diabetes Mellitus Clinical Decision Support (PreDM CDS) intervention and evaluated its impact on clinical outcomes.

Primary Outcome

Mean differences in rates of hemoglobin A1c orders between treatment arms evaluated using mixed models adjusted for clinic site, time between visits, sex, age, race/ethnicity, and baseline cardiometabolic markers.

Trial Details

FieldValue
Enrollment Target 7,424 participants
Start Date 2020-02-27
Est. Completion 2022-09-02
Northwestern University

1,209 total trials

What the finished NCT04335331 record still lists

NCT04335331 is an observational study that tracks outcomes without assigning an intervention. Its 7,424 participants enrollment target places it among the larger protocols in the corpus.

The record links to 0 conditions, and to 0 interventions.

NCT04335331 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT04335331 about?

NCT04335331 is a clinical study titled "PreDM Clinical Decision Support Intervention". Clinical practice guidelines recommend intensive lifestyle interventions and metformin to prevent or delay type 2 diabetes; yet these treatments are not routinely used among the 86 million U.S. adults with prediabetes who may benefit from them. While clinical decision support (CDS) represents an eff...

What is the current status of trial NCT04335331?

This trial is currently completed. The enrollment target is 7,424 participants. The study started on 2020-02-27. Estimated completion is 2022-09-02.

Who is sponsoring clinical trial NCT04335331?

This trial is sponsored by Northwestern University, which has 1,209 total clinical trials registered on ClinicalTrials.gov.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02915198 · 7,410 participants · Phase 4

    Investigation of Metformin in Pre-Diabetes on Atherosclerotic Cardiovascular OuTcomes

  • NCT00439049 · 7,500 participants

    Substance Abuse Pre-Treatment Screening Study

  • NCT04809740 · 7,500 participants · NA

    Evaluating the Implementation and Impact of Navigator-delivered ePRO System

  • NCT05199701 · 7,500 participants · NA

    Prospective Case Collection Study for New Mammography Technologies

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT04335331, the US trial registry maintained by the National Library of Medicine. NCT04335331 (large enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.